<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Early identification of individuals who are at risk of developing <z:hpo ids='HP_0005110'>atrial fibrillation</z:hpo> (AF) and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> may enable a closer surveillance and thus prompt initiation of oral anticoagulation for <z:hpo ids='HP_0001297'>stroke</z:hpo> prevention </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: This study sought to investigate whether <z:hpo ids='HP_0001635'>congestive heart failure</z:hpo>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, age ≥ 75 years, <z:mp ids='MP_0002055'>diabetes</z:mp>, previous <z:hpo ids='HP_0001297'>stroke</z:hpo> (CHADS(2)) and CHA(2)DS(2)-<z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e>, age 65-74 years, sex category (CHA(2)DS(2)-VASc) scores can predict new-<z:hpo ids='HP_0003674'>onset</z:hpo> AF and/or <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in patients presenting with arrhythmic symptoms </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS AND RESULTS: We prospectively followed up 528 patients (68.5 ± 10.6 years, male 46.2 %) presented for assessment of arrhythmic symptoms but without any documented <z:hpo ids='HP_0011675'>arrhythmia</z:hpo>, including AF for development of new-<z:hpo ids='HP_0003674'>onset</z:hpo> AF and/or <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Their mean CHADS(2) and CHA(2)DS(2)-VASc scores on presentation were 1.3 ± 1.3 and 2.3 ± 1.5, respectively </plain></SENT>
<SENT sid="4" pm="."><plain>After 6.1 years, 89 patients (16.8 %, 2.77 per 100 patient-years) had documented AF, and 65 patients (12.3 %, 2.0 per 100 patient-years) suffered <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Both the CHADS(2) (C statistic 0.63, 95 % confidence interval (CI) 0.58-0.67, P &lt; 0.0001, optimal cutoff at 1) and CHA(2)DS(2)-VASc (C statistic 0.63, 95 % CI 0.59-0.67, P &lt; 0.0001, optimal cutoff at 2) scores provided similar prediction for the new-<z:hpo ids='HP_0003674'>onset</z:hpo> AF </plain></SENT>
<SENT sid="6" pm="."><plain>Similarly, CHADS(2) (C statistic 0.69, 95 % CI 0.65-0.73, P &lt; 0.0001, optimal cutoff at 2) and CHA(2)DS(2)-VASc (C statistic 0.69, 95 % CI 0.65-0.73, P &lt; 0.0001, optimal cutoff at 2) have compatible efficacy for <z:hpo ids='HP_0001297'>stroke</z:hpo> prediction in this Chinese population </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The CHADS(2) and CHA(2)DS(2)-VASc scores can be used in patients who presented with arrhythmic symptoms to identify those who are at risk with developing new-<z:hpo ids='HP_0003674'>onset</z:hpo> clinical AF and <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> for close clinical surveillance and early intervention </plain></SENT>
</text></document>